Directors’ Dealings | 30 June 2016 14:48

DGAP-DD: STADA Arzneimittel AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a service of EQS Group AG. The person with duty of notification is solely responsible for the content of this announcement. ————————————————————————— Details of the person subject to the disclosure requirement Last name: Retzlaff First name: Luis Paul Relationship to a person performing managerial responsibilities: Dependent child Details of the person performing managerial responsibilities Position: Member of a managing body Information about the transaction with duty of notification Description of the financial instrument: STADA Arzneimittel AG, Registered shares with restricted transferability and without par value ISIN/WKN of the financial instrument: DE0007251803 Type of transaction: Sale Date: 24.06.2016 Price: 44.207 Currency: EUR No. of items: 3000 Total amount traded: 132621.00 Place: Xetra Information about the company with duty of publication Issuer: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany ISIN: DE0007251803 WKN: 725180 End of Directors’ Dealings Notification (c) DGAP 30.06.2016 DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de ID 26085